Boyd v. Coventry Health Care Inc., 299 F.R.D. 451

ERISA class action alleging fiduciaries breached duties by continuing Coventry stock investments as Plan assets during 2007–2008.
Settlement sought: $3.6 million common fund, distribution pro rata with de minimis $50 threshold, release of claims, and appointment of class counsel.
Two mediation rounds (private and with Magistrate Judge Connelly) preceded the stipulation of settlement (ECF No. 77).
Class certified preliminarily; notice sent to over 20,000 participants with no objections by class members.
Final motions sought: final class certification, final settlement approval, plan of allocation, attorneys’ fees, expenses, and named-plaintiff incentive payments.
Court granted final approval with a reduction of attorneys’ fees to $1,000,000 (about 28% of the fund) after cross-checking with lodestar.

Issue	Plaintiff's Argument	Defendant's Argument	Held
Whether the Settlement Class should be finally certified	Named Plaintiffs contend Rule 23(a) and 23(b)(1) criteria are met.	Coventry disputes nothing; claims commonality and manageability adequate for certification.	Final certification granted.
Whether the Settlement Agreement is fair, reasonable, and adequate	Settlement achieved substantial value given liability uncertainties and damages proof difficulties.	Settlement may undercompensate some plaintiffs; defense concerns about liability risk remain.	Settlement approved.
Whether the Plan of Allocation is fair and reasonable	Allocation based on relative declines in Coventry stock with equal treatment; de minimis threshold applies.	Plan fairly distributes net settlement; no objections raised.	Plan of Allocation approved.
Whether attorneys’ fees and expenses are reasonable	One-third of the fund requested with lodestar cross-check supporting reasonableness.	Fees may be excessive given risks and public policy concerns.	Overall fees reduced to $1,000,000 (about 28%), with expenses approved.
Whether incentive payments to Named Plaintiffs are reasonable	Named Plaintiffs contributed significant time and effort over four years.	Incentives common in ERISA settlements; modest amount appropriate.	Incentive payments of $5,000 to each Named Plaintiff approved.

Amchem Prods., Inc. v. Windsor, 521 U.S. 591 (S. Ct. 1997) (settlement class scrutiny heightened; ensure fairness and adequacy)
Wal-Mart Stores, Inc. v. Dukes, 131 S. Ct. 2541 (U.S. 2011) (class-wide resolution must be able to be determined in one stroke)
Langbecker v. Elec. Data Sys. Corp., 476 F.3d 299 (5th Cir. 2007) (factors for evaluating ERISA damages and complex claims)
Deiter v. Microsoft Corp., 436 F.3d 461 (4th Cir. 2006) (typicality and adequacy in class actions; named plaintiffs' claims mirror class claims)
In re Schering-Plough Corp. ERISA Litig., 589 F.3d 585 (3d Cir. 2009) (ERISA fiduciary duties in company stock cases; class certification under 23(b)(1))
In re Cendant Corp. PRIDES Litig., 243 F.3d 722 (3d Cir. 2001) (reference for common-fund fee considerations)
In re Broadwing, Inc. ERISA Litig., 252 F.R.D. 369 (S.D. Ohio 2006) (complexity and discovery considerations in ERISA stock cases)
In re Microsoft Corp. ERISA Litig., 461 F. Supp. 2d 1040 (S.D. Cal. 2006) (lodestar cross-check and percentage-of-recovery interplay)